Skip to content

GESTIFAR

Active Private limited companyfounded 1990active for 36 yearsRue Emile Vandervelde 3, 7332 Saint-GhislainKBO/BCE: BE 0441.670.890 #4 company by equity in Saint-Ghislain, Professional and technical services sector
GESTIFAR
Follow ReportCompare

Timeline

46 events since 1990

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 42 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0441670890
Annual accounts 2024 filed PDFfull format · 38 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 39 days before the deadline
2023
Back to profit net €3,125 The net result is €3,125, after one loss-making year.
Annual accounts 2022 filed PDFfull format · 28 days late
2022
Weakest financial year net -€37,790 The net result drops to -€37,790, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2021 filed PDFfull format · 6 days before the deadline
Merger: GESTIFAR takes over PHARMA SERVICESCapital increase of €17,496.02 to €48,771.02 · Capital from €31,275 to €48,771.02 · Appointments: VANDERELST Jean-Christophe Marcel Willy (statutory director) and Catherine BROWET (statutory director) · General meeting of 17-06-20227 points ▸
  • Capital increase, €17,496.02
  • Amendment of the articles, article 5
  • Director appointment, VANDERELST Jean-Christophe Marcel Willy (statutory director)
  • Director appointment, Catherine BROWET (statutory director)
  • Registered office clause, rue Emile Vandervelde 3, 7332 Saint-Ghislain (ex-Sirault)
  • General meeting, 17-06-2022
  • Accounting effect, 01-01-2022
  • The deed holds 18 more points.

Open the deed in the Belgian Official Gazette

2021
Annual accounts 2020 filed PDFfull format · 19 days late
Merger proposal: GESTIFAR takes over Pharma ServicesCapital increase of €30,988.52 to €62,000 · Capital from €31,011.48 to €62,000 · Permanent representative: Jean-Christophe Vanderelst12 points ▸
  • Capital, €62,000, 1,251 shares
  • Founding capital, €31,011.48, 1,251 shares
  • Capital increase, €30,988.52
  • Capital, €18,550, 880 shares
  • Founding capital, €61,973.38, 250 shares
  • Capital increase, €156,065.39
  • Capital decrease, €108,038.77
  • Capital decrease, €91,450
  • Permanent representative, Jean-Christophe Vanderelst
  • The company holds 50 shares of Pharma Services
  • Capital increase, €17,496.02
  • Accounting effect, 01-01-2021
  • The deed holds 19 more points.

Open the deed in the Belgian Official Gazette

2020
Annual accounts 2019 filed PDFfull format · 38 days late
2019
Back to profit net €251,677 The net result is €251,677, after one loss-making year.
Equity above €2m equity €2.1m ▲13.9% Equity rises from €1.8m to €2.1m.
Annual accounts 2018 filed PDFmicro format · 19 days late
2018
Annual accounts 2017 filed PDFmicro format · 23 days late
2017
Annual accounts 2016 filed PDFmicro format · 18 days late
2016
Annual accounts 2015 filed PDFfull format · 23 days late
2015
Annual accounts 2014 filed PDFfull format · 66 days before the deadline
2014
Highest result from 2006 to 2025 net €277,255 ▲5,996% The net result of €277,255 is the highest of those years.
Annual accounts 2013 filed PDFfull format · 43 days before the deadline
2013
Annual accounts 2012 filed PDFfull format · 9 days before the deadline
2012
Annual accounts 2011 filed PDFfull format · 32 days before the deadline
2011
Liquidity more than triples current ratio 2.90 The current ratio rises from 0.74 to 2.90. Short-term debt falls from €793,819 to €153,521.
Annual accounts 2010 filed PDFfull format · 40 days before the deadline
2010
Annual accounts 2009 filed PDFfull format · 30 days late
2009
Annual accounts 2008 filed PDFfull format · 35 days before the deadline
2008
Annual accounts 2007 filed PDFfull format · 20 days late
2007
Annual accounts 2006 filed PDFfull format · 49 days before the deadline
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
2000
Annual accounts 1999 filed PDFfull format
1999
Annual accounts 1998 filed PDFfull format
1998
Annual accounts 1997 filed PDFfull format
Annual accounts 1996 filed PDFfull format
1996
Annual accounts 1995 filed PDFfull format
1995
Annual accounts 1994 filed PDFfull format
1994
Annual accounts 1993 filed PDFfull format
1993
Annual accounts 1992 filed PDFfull format
1992
Annual accounts 1991 filed PDFfull format
1990
First establishment Rue Emile Vandervelde 3, Saint-Ghislain
Incorporation published on 17-10-1990

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

GESTIFAR was incorporated on 25 September 1990.1 Between 2021 and 2022 the capital was increased 2 times, most recently to €48,771.23 In 2022 the company absorbed PHARMA SERVICES by merger.3 Total assets went from €3.1m in 2022 to €3.2m in 2025 and headcount from 1.2 to 1.1 full-time equivalents.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 01-07-2021
  3. 3Belgian Official Gazette, 14-07-2022
  4. 4National Bank, annual accounts 2022 and 2025

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure